FEBS Journal

Scope & Guideline

Connecting Researchers to Transformative Discoveries

Introduction

Immerse yourself in the scholarly insights of FEBS Journal with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1742-464x
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2005 to 2024
AbbreviationFEBS J / FEBS J.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The FEBS Journal publishes high-quality research articles that span a wide range of topics in biochemistry, molecular biology, and cellular biology. The journal aims to advance our understanding of biological processes at the molecular level, with a focus on the mechanisms underlying disease and potential therapeutic interventions.
  1. Biochemical and Molecular Mechanisms:
    The journal emphasizes studies that elucidate the biochemical pathways and molecular mechanisms underpinning cellular functions and disease processes, including signaling pathways, metabolic regulation, and enzyme function.
  2. Structural Biology and Biophysics:
    Research involving the structural characterization of biological macromolecules such as proteins and nucleic acids, utilizing techniques like X-ray crystallography, NMR, and cryo-electron microscopy, is a core focus.
  3. Cellular and Developmental Biology:
    The journal covers research on cellular processes, including cell differentiation, growth, and apoptosis, as well as developmental biology, exploring how these processes are regulated at the molecular level.
  4. Cancer Biology and Therapeutics:
    A significant emphasis is placed on studies related to cancer biology, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic strategies.
  5. Immunology and Microbiology:
    The journal publishes articles on immune responses, pathogen-host interactions, and the microbiome's role in health and disease, reflecting the growing interest in these areas.
  6. Neurobiology and Neurodegeneration:
    Research addressing the molecular mechanisms of neurodegenerative diseases, neuroinflammation, and neuronal signaling is prominently featured, highlighting the journal's commitment to understanding brain health.
The FEBS Journal has experienced a notable evolution in its focus areas, with several emerging themes reflecting current scientific trends and societal needs. These trends indicate a shift towards more interdisciplinary and applied research.
  1. Cancer Immunotherapy:
    Publications focusing on cancer immunotherapy have surged, highlighting the importance of understanding immune responses to tumors and the development of novel immunotherapeutic strategies.
  2. Microbiome Research:
    The role of the microbiome in health and disease is increasingly prominent, with studies examining its impact on various physiological processes and its potential as a therapeutic target.
  3. Cellular Senescence and Aging:
    Research on cellular senescence, its role in aging, and its implications for age-related diseases is gaining traction, reflecting a growing interest in understanding the biological mechanisms of aging.
  4. Gene Editing Technologies:
    The application of CRISPR and other gene editing technologies is increasingly featured, focusing on their potential for therapeutic interventions and understanding genetic diseases.
  5. Metabolism and Disease:
    Emerging studies on the links between metabolism, metabolic disorders, and diseases such as cancer and neurodegeneration are becoming more common, emphasizing the importance of metabolic pathways in health.
  6. Extracellular Vesicles:
    Research on extracellular vesicles and their roles in cell communication, disease progression, and potential therapeutic applications is gaining popularity, reflecting their significance in various biological processes.

Declining or Waning

While the FEBS Journal has maintained a broad focus on various aspects of biochemistry and molecular biology, certain themes appear to be declining in prominence over recent years. This may reflect shifts in research priorities or emerging fields of interest.
  1. Basic Enzyme Kinetics:
    Research focusing solely on basic enzyme kinetics has seen a decline, as the field increasingly emphasizes the integration of kinetic studies with structural biology and functional assays.
  2. Traditional Pharmacology:
    There is a noticeable reduction in studies centered on traditional pharmacological approaches, as the focus shifts towards molecular and genetic therapies, particularly in the context of cancer and chronic diseases.
  3. Plant Biochemistry:
    While still relevant, the volume of research specifically addressing plant biochemistry and physiology appears to be waning, potentially due to a shift towards more applied or translational research in agricultural biotechnology.
  4. Studies on Model Organisms:
    Research utilizing model organisms like yeast or Drosophila for basic biological questions is less frequent, with a trend towards more complex systems that reflect human biology more closely.
  5. In Vitro Assays:
    There seems to be a decline in the publication of studies relying solely on in vitro assays without further validation in vivo, as the scientific community increasingly values comprehensive approaches that include physiological relevance.

Similar Journals

MOLECULAR AND CELLULAR BIOCHEMISTRY

Illuminating the Path of Molecular Discoveries
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

FEBS LETTERS

Pioneering New Ideas in Biochemistry and Genetics
Publisher: WILEYISSN: 0014-5793Frequency: 24 issues/year

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

Cell Communication and Signaling

Connecting Scientists Through Open Access Discoveries
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

Cell Reports

Connecting Scientists to Transformative Discoveries
Publisher: CELL PRESSISSN: 2211-1247Frequency: 48 issues/year

Cell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.

Biochemistry and Cell Biology

Fostering collaboration and knowledge in the heart of biochemistry and cell biology.
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0829-8211Frequency: 6 issues/year

Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.

CELLULAR AND MOLECULAR BIOLOGY

Transforming Knowledge in Cellular and Molecular Biology
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

CELLULAR SIGNALLING

Pioneering Research in Cellular Signalling
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

CELL PROLIFERATION

Bridging Knowledge Gaps in Cell Proliferation Studies
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

Genes & Diseases

Pioneering research for a healthier tomorrow.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Bridging Gaps in Cellular Research for a Global Audience
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.